Skip to content

Clinical trials

Expanded access trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Netherlands Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available9
Approved for marketing7
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Bayer2
Novartis Pharmaceuticals2
Nuvalent Inc.2
Tibotec Pharmaceuticals, Ireland2
BioMarin Pharmaceutical1
Bristol-Myers Squibb1
Eisai Inc.1
Eli Lilly and Company1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung2
Breast Neoplasms1
COVID-191
Carcinoma, Renal Cell1
Colorectal Neoplasms1
Cystitis1
Dermatitis, Atopic1
Eczema1
Gastrointestinal Neoplasms1
HIV Infections1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.